External validation and adaptation of a dynamic prediction model for patients with high‐grade extremity soft tissue sarcoma
Journal of Surgical Oncology2020Vol. 123(4), pp. 1050–1056
Citations Over TimeTop 14% of 2020 papers
Anja J. Rueten‐Budde, Veroniek M. van Praag, Michiel A. J. van de Sande, Marta Fiocco, PERSARC Study Group
Abstract
Results from the external validation show that the dynamic PERSARC model is reliable in predicting the probability of surviving an additional 5 years from a specific prediction time point during follow-up. The model combines patient-, treatment-specific and time-dependent variables such as local recurrence and distant metastasis to provide accurate survival predictions throughout follow-up and is available through the PERSARC app.
Related Papers
- → Expanding soft tissue with Osmed® tissue expanders in the goat maxilla(2010)20 cited
- → Non-rhabdomyosarcoma Soft-Tissue Sarcoma(2016)5 cited
- [Accomplishments of tumor surgery in soft tissue sarcoma in childhood].(1988)
- → CLINICAL PRACTICE GUIDELINES FOR MANAGEMENT OF SARCOMA: DOES SURGERY AT A SPECIALIZED SARCOMA CENTRE IMPROVE OUTCOMES?(2023)
- → Imaging Appearances of the Most Common Malignant and Benign Lesions from a Regional Soft Tissue Sarcoma Diagnostic Center(2023)